Related Experiment Video
Updated: May 31, 2025

07:40
Large-Scale, Automated Production of Adipose-Derived Stem Cell Spheroids for 3D Bioprinting
Published on: March 31, 2022
2.5K
Deep Learning for Predicting Spheroid Viability: Novel Convolutional Neural Network Model for Automating Quality
Zyva A Sheikh1, Oliver Clarke1, Amatullah Mir1
1Section of Cardiac Surgery, Department of Surgery, University of Chicago, 5841 S. Maryland Ave., Chicago, IL 60637, USA.
Bioengineering (Basel, Switzerland)
|January 24, 2025
Summary
A new deep-learning model accurately predicts spheroid viability from images, overcoming limitations of traditional assays. This accelerates the development of bioprinted tissues for cardiovascular disease therapies.
Area of Science:
- Biotechnology
- Tissue Engineering
- Artificial Intelligence
Background:
- Spheroids are crucial for 3D bioprinted tissue patches but can develop hypoxic cores and necrosis when larger than 500 μm.
- Accurate spheroid viability assessment is essential for fabricating high-viability tissue patches.
- Current viability assays are often time-consuming, labor-intensive, require expertise, and are prone to human bias.
Purpose of the Study:
- To develop a convolutional neural network (CNN) model for efficient and accurate prediction of spheroid viability using phase-contrast imaging.
- To establish a comprehensive dataset of mouse mesenchymal stem cell (mMSC) spheroids with corresponding viability percentages.
- To automate the classification of spheroid viability into predefined categories.
Main Methods:
- A dataset of mMSC spheroids with varying sizes and viabilities (determined by CCK-8 assays) was created.
- A CNN model was trained and validated using this dataset.
- The model was designed to classify spheroid viability into four ranges: 0-20%, 20-40%, 40-70%, and 70-100%.
Main Results:
- The CNN model achieved an average accuracy of 92% in predicting spheroid viability.
- The model demonstrated a consistent loss below 0.2 during training and validation.
- The model successfully classified spheroids into the defined viability categories.
Conclusions:
- The developed deep-learning model provides a non-invasive, efficient, and accurate method for assessing spheroid quality.
- This approach streamlines spheroid quality control, accelerating the development of bioengineered cardiac tissue patches.
- The model holds significant potential for advancing cardiovascular disease therapies through improved tissue engineering.

